NO170667C - Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel - Google Patents

Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel

Info

Publication number
NO170667C
NO170667C NO840725A NO840725A NO170667C NO 170667 C NO170667 C NO 170667C NO 840725 A NO840725 A NO 840725A NO 840725 A NO840725 A NO 840725A NO 170667 C NO170667 C NO 170667C
Authority
NO
Norway
Prior art keywords
procedure
preparation
useful agent
device rendering
osmose device
Prior art date
Application number
NO840725A
Other languages
English (en)
Norwegian (no)
Other versions
NO840725L (no
NO170667B (no
Inventor
George V Guittard
Felix Theeuwes
Joseph C Deters
Richard Cortese
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO840725L publication Critical patent/NO840725L/no
Publication of NO170667B publication Critical patent/NO170667B/no
Publication of NO170667C publication Critical patent/NO170667C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
NO840725A 1983-03-04 1984-02-27 Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel NO170667C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/472,333 US4576604A (en) 1983-03-04 1983-03-04 Osmotic system with instant drug availability

Publications (3)

Publication Number Publication Date
NO840725L NO840725L (no) 1984-09-05
NO170667B NO170667B (no) 1992-08-10
NO170667C true NO170667C (no) 1992-11-18

Family

ID=23875096

Family Applications (1)

Application Number Title Priority Date Filing Date
NO840725A NO170667C (no) 1983-03-04 1984-02-27 Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel

Country Status (22)

Country Link
US (1) US4576604A (fr)
JP (1) JPS59167513A (fr)
AT (1) AT397179B (fr)
AU (1) AU568621B2 (fr)
BE (1) BE898820A (fr)
BR (1) BR8400997A (fr)
CA (1) CA1242122A (fr)
CH (1) CH660124A5 (fr)
DE (1) DE3407873A1 (fr)
DK (1) DK162470C (fr)
ES (1) ES530268A0 (fr)
FR (1) FR2541896B1 (fr)
GB (1) GB2135880B (fr)
IE (1) IE56606B1 (fr)
IL (1) IL71112A (fr)
IT (1) IT1182253B (fr)
MX (1) MX165227B (fr)
NL (1) NL192720C (fr)
NO (1) NO170667C (fr)
NZ (1) NZ206988A (fr)
SE (1) SE459847B (fr)
ZA (1) ZA84259B (fr)

Families Citing this family (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571922B2 (en) * 1984-01-26 1988-04-28 Schering Agrochemicals Limited Veterinary implants comprising melatonin and derivatives thereof
US4618487A (en) * 1984-07-06 1986-10-21 Alza Corporation Device for administering calcium ascorbate
US4769027A (en) * 1984-08-15 1988-09-06 Burroughs Wellcome Co. Delivery system
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US4643731A (en) * 1985-08-16 1987-02-17 Alza Corporation Means for providing instant agent from agent dispensing system
US4698062A (en) * 1985-10-30 1987-10-06 Alza Corporation Medical device for pulsatile transdermal delivery of biologically active agents
US4898733A (en) * 1985-11-04 1990-02-06 International Minerals & Chemical Corp. Layered, compression molded device for the sustained release of a beneficial agent
US4662880A (en) * 1986-03-14 1987-05-05 Alza Corporation Pseudoephedrine, brompheniramine therapy
US4857330A (en) * 1986-04-17 1989-08-15 Alza Corporation Chlorpheniramine therapy
ES2019634B3 (es) * 1986-04-17 1991-07-01 Alza Corp Terapia con clorfeniramina.
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
EP0271438B1 (fr) * 1986-11-14 1992-04-29 Ciba-Geigy Ag Système osmotique oral pour le metoprolol avec une composition particulière
JPS63135179A (ja) * 1986-11-26 1988-06-07 立花　俊郎 薬物の経皮投与具
US4801461A (en) 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
US4915952A (en) * 1987-02-27 1990-04-10 Alza Corporation Composition comprising drug, HPC, HPMC and PEO
US4810502A (en) * 1987-02-27 1989-03-07 Alza Corporation Pseudoephedrine brompheniramine therapy
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
GR1000252B (el) * 1988-09-02 1992-05-12 Alza Corp Μορφη δοσολογιας συνισταμενη απο ταχεια απελευθερωση δραστικου παραγοντα ακολουθουμενη απο βραδεια απελευθερωση δραστικου παραγοντα.
US5034229A (en) 1988-12-13 1991-07-23 Alza Corporation Dispenser for increasing feed conversion of hog
US4969884A (en) * 1988-12-28 1990-11-13 Alza Corporation Osmotically driven syringe
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
US5200197A (en) * 1989-11-16 1993-04-06 Alza Corporation Contraceptive pill
US5045082A (en) * 1990-01-10 1991-09-03 Alza Corporation Long-term delivery device including loading dose
US5071607A (en) * 1990-01-31 1991-12-10 Alza Corporatino Method and apparatus for forming a hole in a drug dispensing device
US5192550A (en) * 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5187100A (en) * 1990-05-29 1993-02-16 Lifescan, Inc. Dispersion to limit penetration of aqueous solutions into a membrane
US5128145A (en) * 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
EP0542926B1 (fr) * 1990-08-07 1995-02-15 Pfizer Inc. Emploi de membranes a polymerisation interfaciale dans des dispositifs de liberation
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5429822A (en) * 1992-03-13 1995-07-04 Cambridge Scientific, Inc. Biodegradable bursting release system
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US5540665A (en) * 1994-01-31 1996-07-30 Alza Corporation Gas driven dispensing device and gas generating engine therefor
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5672357A (en) * 1994-07-01 1997-09-30 Monsanto Company Method and device for implantation of large diameter objects in bovines
US5595752A (en) * 1994-07-01 1997-01-21 Monsanto Company Increasing dressing percentage and carcass weight in finishing beef cattle
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
US5529787A (en) * 1994-07-07 1996-06-25 Alza Corporation Hydromorphone therapy
US6491945B1 (en) * 1994-09-16 2002-12-10 Alza Corporation Hydrocodone therapy
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
EP0914097B1 (fr) * 1996-03-12 2002-01-16 Alza Corporation Composition et forme galenique contenant un antagoniste des opioides
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5948787A (en) * 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
AU7706598A (en) * 1997-05-30 1998-12-30 Laboratorios Phoenix U.S.A., Inc. Multi-layered osmotic device
US8524277B2 (en) * 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US20020127254A1 (en) * 1998-06-25 2002-09-12 Lavipharm Laboratories Inc. Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US20090297602A1 (en) * 1998-11-02 2009-12-03 Devane John G Modified Release Loxoprofen Compositions
US6198966B1 (en) 1999-02-26 2001-03-06 Medtronic, Inc. Recirculating implantable drug delivery system
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
US6264973B1 (en) * 1999-08-26 2001-07-24 Fei Enterprises, Ltd. Apparatus and method for anesthetizing the cervical region of a female
ES2233611T3 (es) 2000-02-04 2005-06-16 Alza Corporation Dispensador de fluidos de accionamiento osmotico.
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
AU2001281729A1 (en) * 2000-07-14 2002-01-30 Novo-Nordisk A/S Method of moulding a pharmaceutical composition in a packaging material
ATE330586T1 (de) * 2001-03-14 2006-07-15 Pfizer Prod Inc Pharmazeutische tablette und eine verfahren zu deren herstellung
US6632217B2 (en) * 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
US20040253312A1 (en) 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
WO2003026615A2 (fr) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Formes de dosage a liberation modifiee
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US8454997B2 (en) * 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
JP4615862B2 (ja) * 2001-12-18 2011-01-19 ノボ・ノルデイスク・エー／エス 固形投与マイクロインプラント
EP2422773A3 (fr) 2002-09-20 2012-04-18 Alpharma, Inc. Séquestration de sous-unité et compositions et procédés associés
RU2005108577A (ru) 2002-09-28 2006-06-10 МакНЕЙЛ-ППС, ИНК. (US) Дозированные формы с модифицированным высвобождением
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
MXPA06003150A (es) * 2003-09-17 2006-08-31 Johnson & Johnson Compuestos heterociclicos fusionados.
CA2540047A1 (fr) * 2003-09-26 2005-04-07 Alza Corporation Baton poussoir oros<sp>r </sp>pour l'administration controlee d'agents actifs
KR101169614B1 (ko) * 2003-09-26 2012-08-03 알자 코포레이션 상승한 방출 속도를 나타내는 제어 방출 제제
MXPA06003454A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada de analgesicos opioides y no opiodes.
CN1897924B (zh) 2003-09-26 2011-09-21 阿尔扎公司 能提供高载药量的药物包衣和提供它的方法
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US20050196447A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196448A1 (en) * 2004-03-05 2005-09-08 Hai Yong Huang Polymeric compositions and dosage forms comprising the same
US20050196446A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US20050196442A1 (en) * 2004-03-05 2005-09-08 Huang Hai Y. Polymeric compositions and dosage forms comprising the same
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
EP1811974A4 (fr) * 2004-11-05 2012-03-07 Glaxosmithkline Llc Dispositif et procede d'analyse pharmaceutique
US20060104931A1 (en) * 2004-11-12 2006-05-18 Takeshi Fukutome Cosmetic treatment article comprising substrate and gel composition
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
US7530804B2 (en) * 2004-12-07 2009-05-12 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
US8673352B2 (en) * 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US20060233882A1 (en) * 2005-04-15 2006-10-19 Sowden Harry S Osmotic dosage form
US7884136B2 (en) 2005-06-27 2011-02-08 Biovail Laboratories International S.R.L. Modified-release formulations of a bupropion salt
US7598255B2 (en) 2005-08-04 2009-10-06 Janssen Pharmaceutica Nv Pyrimidine compounds as serotonin receptor modulators
WO2007073702A2 (fr) * 2005-12-29 2007-07-05 Osmotica Corp. Comprime a couches multiples a liberation par triple combinaison
WO2007120690A2 (fr) * 2006-04-10 2007-10-25 Janssen Pharmaceutica N.V. Thérapie combinée avec des antagonistes des récepteurs histaminiques h1r et h4r pour le traitement du prurit
US8137327B2 (en) * 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
DK2034975T3 (da) * 2006-06-19 2012-07-23 Alpharma Pharmaceuticals Llc Farmaceutiske sammensætninger
EP2068840A2 (fr) * 2006-07-21 2009-06-17 LAB International SRL Système de délivrance hydrophobe empêchant les utilisations abusives
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
CA2709992A1 (fr) * 2007-12-17 2009-07-16 Alpharma Pharmaceuticals, Llc Compositions pharmaceutiques d'agonistes opioides resistant aux abus
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
US20090311335A1 (en) * 2008-06-12 2009-12-17 Scott Jenkins Combination of a triptan and an nsaid
EP2328539B1 (fr) 2008-09-25 2018-04-18 ISP Investments LLC Composition d enrobage de comprimés lisse à haute teneur en particules solides
DE102008059206A1 (de) * 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
BRPI1010301A2 (pt) * 2009-04-09 2016-03-15 Alkermes Pharma Ireland Ltd composição.
EA201492026A1 (ru) 2012-05-07 2015-09-30 Байер Фарма Акциенгезельшафт Способ изготовления фармацевтической лекарственной формы, содержащей нифедипин и кандесартан цилексетил
EP3076946A1 (fr) 2013-12-06 2016-10-12 Durect Corporation Compositions comprenant un antioxydant, des distributeurs de liquide, et procédés impliquant ceux-ci
WO2017168174A1 (fr) 2016-04-02 2017-10-05 N4 Pharma Uk Limited Nouvelles formes pharmaceutiques du sildénafil
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii
WO2018115888A1 (fr) 2016-12-21 2018-06-28 N4 Pharma Uk Limited Nouvelles formulations d'aprépitant
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US10376471B2 (en) 2017-07-10 2019-08-13 Gel Cap Technologies, LLC Dual release dosage form capsule and methods, devices and systems for making same
WO2019023617A1 (fr) * 2017-07-27 2019-01-31 University Of Utah Research Foundation Dispositif d'administration de produit thérapeutique

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2099402A (en) * 1934-01-17 1937-11-16 Pratt Food Company Pill or tablet
US2921001A (en) * 1957-04-16 1960-01-12 Sterling Drug Inc Multi-layered pill or tablet with indicating lamination
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3625214A (en) * 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
AU466503B2 (en) * 1972-06-05 1975-10-30 Alza Corporation Osmotic dispenser
US4096238A (en) * 1974-12-23 1978-06-20 Alza Corporation Method for administering drug to the gastrointestinal tract
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
US4455143A (en) * 1982-03-22 1984-06-19 Alza Corporation Osmotic device for dispensing two different medications

Also Published As

Publication number Publication date
IT1182253B (it) 1987-10-05
GB2135880A (en) 1984-09-12
AT397179B (de) 1994-02-25
SE8401185D0 (sv) 1984-03-02
SE8401185L (sv) 1984-09-05
NL8400670A (nl) 1984-10-01
NZ206988A (en) 1986-04-11
CH660124A5 (de) 1987-03-31
SE459847B (sv) 1989-08-14
FR2541896A1 (fr) 1984-09-07
JPS59167513A (ja) 1984-09-21
IL71112A0 (en) 1984-05-31
DE3407873C2 (fr) 1992-10-08
BR8400997A (pt) 1984-10-09
IE56606B1 (en) 1991-10-09
NO840725L (no) 1984-09-05
BE898820A (fr) 1984-05-30
GB2135880B (en) 1986-10-01
ES8503499A1 (es) 1985-03-01
JPS644489B2 (fr) 1989-01-25
CA1242122A (fr) 1988-09-20
US4576604A (en) 1986-03-18
GB8400563D0 (en) 1984-02-15
DE3407873A1 (de) 1984-09-06
ES530268A0 (es) 1985-03-01
AU2306884A (en) 1984-09-06
NO170667B (no) 1992-08-10
AU568621B2 (en) 1988-01-07
DK88884A (da) 1984-09-05
DK162470B (da) 1991-11-04
ATA72784A (de) 1993-07-15
DK88884D0 (da) 1984-02-22
DK162470C (da) 1992-04-06
IL71112A (en) 1986-09-30
NL192720B (nl) 1997-09-01
MX165227B (es) 1992-10-30
IT8467204A0 (it) 1984-03-02
IE840156L (en) 1984-09-04
ZA84259B (en) 1985-02-27
NL192720C (nl) 1998-01-06
FR2541896B1 (fr) 1987-07-24

Similar Documents

Publication Publication Date Title
NO170667C (no) Fremgangsmaate for fremstilling av en osmose-anordning foravgivelse av et nyttig middel
FI840800A0 (fi) Doseringsanordning foer pastoesa produkter
RO90861A (fr) Procede pour la preparation de l&#39;ethylenglycole
NO170834C (no) Fremgangsmaate til fremstilling av en osmoseanordning for avgivelse av et nyttig middel
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
DK25484A (da) Diagnostisk middel
IT1176163B (it) Dispositivo assortitore
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
ES547466A0 (es) Procedimiento de preparacion de derivados aminometilfosfoni-cos
ES530955A0 (es) Dispositivo para la alineacion de pliegos
BR8305291A (pt) Dispositivo anti-ofuscante
SE8406336L (sv) Anordning for orientering av foremal
RO90231A (fr) Dispositif de sustentation
ES551558A0 (es) Procedimiento de preparacion de 20-ceto-delta16-esteroides
NO844809L (no) Fremgangsmaate for fremstilling av polyfenylenoksyd
RO88757A2 (fr) Dispositif pour limiter la course de la grue
NO844807L (no) Fremgangsmaate for fremsvilling av polyfenylenoksyd
NO834534L (no) Forbindelsesinnretning
SE8300412D0 (sv) Anordning for plogning/schaktning
NO832843L (no) Fremgangsmaate for fremstilling av nitroalkaner
SE8306081D0 (sv) Anordning for forflyttning av foremal
BR6301461U (pt) Aparelho de diatermia
RO86952A2 (fr) Installation pour l&#39;ebardage des pieces
RO87977A2 (fr) Procede pour obtenir cis-diclordiaminoplatine
RO84954A2 (fr) Procede pour l&#39;obtention des alkylbenzenes

Legal Events

Date Code Title Description
MK1K Patent expired